Arquivamento definitivo - Art. 33 da LPI
#11.1.1
12/17/2024
RPI 2815
Application data
Number
112023005091Type
Filing
Publication
PCT
IL2021051144 The application was abandoned: examination was not requested within the 36 months following the 09/20/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.
Applicants
BIOSIGHT LTD.
IL
Inventors
M. S. (pessoa física)
IL
R. L. (pessoa física)
IL
S. T. (pessoa física)
IL
IPC Classification
Priority claims
US
63/080,808 · 09/21/2020
Abstract
FORMA CRISTALINA DA ASPACITARABINA. A presente invenção se refere a um novo polimorfo cristalino do ácido (S)-2-amino-4-((1-((2R,3S,4S,5R)-3,4-di-hidroxi-5-(hidroximetil)tetrai-hidrofuran-2-il)-2-oxo-1,2-di-hidropirimidin-4-il)-4-oxobutanoico (também conhecido como BST-236, Astarabina® ou aspacitarabina), processos de preparação do mesmo e usos dos mesmos para o tratamento de doenças neoplásicas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
12/17/2024
RPI 2815
#11.1
10/01/2024
RPI 2804
#1.3
04/18/2023
RPI 2728
#1.1
03/28/2023
RPI 2725
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.